News | News By Subject | News by Disease News By Date | Search News

Hypercholesterolemia (high blood cholesterol) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Gemphire Shares Drop on Disappointing Phase II Results for LDL Drug     8/7/2017
How This New Jersey Biotech is Taking on Amgen (AMGN)     3/27/2017
UCSF Heart Doctor Wary of Amgen (AMGN)-Paid Repatha Study     3/23/2017
Disappointment Hits as Amgen (AMGN)'s Repatha Prevents Heart Attacks, But Not Deaths     3/20/2017
Amgen (AMGN) Shares Soar After Blocking Rivals From Selling Competing Cholesterol-Lowering Drug     1/6/2017
Regeneron (REGN), Sanofi (SNY)'s Potential Blockbuster Praluent Passes Late-Stage Test     8/30/2016
Amgen (AMGN) Responds to 'Flawed' Cholesterol Study     8/23/2016
Esperion (ESPR) Falls on Lack of FDA Clarity for Cholesterol Drug     6/29/2016
Catabasis (CATB) Craters as Cholesterol Drug Flunks Mid-Stage Study     6/8/2016
Amgen (AMGN) Researchers Discover Gene that Cuts Heart Attack Risk     5/23/2016
Regeneron (REGN) CEO Says Critique of the Company's New Cholesterol Lowering Therapy Was Non-Scientific     5/13/2016
3 Biotechs Getting Another Shot After Failed Trials     4/7/2016
Data Behind Eli Lilly (LLY)'s Decision to Halt Potential Cholesterol Blockbuster Released Last Weekend     4/5/2016
Pfizer (PFE)'s Bococizumab Met Primary Endpoints in Phase III Trial     4/1/2016
Amgen (AMGN) to Present 19 Abstracts at American College of Cardiology     3/22/2016

News from Around the Web
First-Of-Its-Kind Cholesterol Test Could Transform The Way Heart Disease Is Predicted, AACC Reveals     6/6/2017
The 5 Best Dividend Stocks In Cholesterol Drugs     5/30/2017
Esperion (ESPR): Up, Up, And Away?     5/18/2017
Obesity And 4 Other Conditions Lead Americans To The Grave, Cleveland Clinic Study     4/28/2017
A Closer Look At Amgen (AMGN)'s Money Back Guarantee For Repatha     4/4/2017
Cholesterol Drug Shows Promise To Help Reverse Heart Disease     11/16/2016
These Pricey Cholesterol Drugs Aren't Selling. And That Has The Biotech Industry Sweating     10/28/2016
Testing Cholesterol In Toddlers, Even Younger? Queen Mary University Of London Study Says It Could Help     10/27/2016
In This War Over Statins, How Can Patients Win?     10/11/2016
A $14,000 Price Tag For A Cholesterol Drug Can Be A Bargain     9/6/2016
Barley Lowers Not One But Two Types Of 'Bad Cholesterol,' St. Michael's Hospital Study Suggests     6/8/2016
Some People Really Can't Take Statins For High Cholesterol, Cleveland Clinic Scientists Reveal     4/5/2016
The Benefits Of Walnuts On Age-Related Health Issues Investigated, Loma Linda University Reveals     4/4/2016
Young Hispanic Pot Smokers Have Lower Odds Of Metabolic Syndrome, University of Miami Study Finds     3/17/2016
No Link Found Between Insomnia And Cholesterol Levels, St. Michael's Hospital Study Reveals     3/3/2016

Press Releases
Gemphire Announces Plans To Advance Gemcabene Into Phase III Clinical Development     9/20/2017
Madrigal Announces Positive Outcome From Pre-Planned DSMB Safety Review And Completion Of Enrollment Of Phase II Study Of MGL-3196 In Patients With Heterozygous Familial Hypercholesterolemia     9/19/2017
Future Unclear For Merck & Co. (MRK)'s Cholesterol Drug As Trial Data Underwhelms     8/29/2017
Alnylam (ALNY) And The Medicines Company (MDCO) Release: New, One-Year Data From ORION-1 Phase II Study Of Inclisiran Extends Excellent Long-Term Efficacy And Safety Profile, Affirming Dose For Phase III Trials     8/28/2017
Gemphire Announces Top-Line Data from COBALT-1 Phase IIb Clinical Trial in HoFH Patients     6/29/2017
Regeneron (REGN) And Sanofi (SNY) Announce Positive Results From First Dedicated Studies Evaluating Praluent (Alirocumab) In Individuals With Diabetes And Hypercholesterolemia     6/12/2017
Regeneron (REGN) Announces ANGPTL3/Evinacumab Publication In The New England Journal of Medicine And Positive Phase ll Data In People With HoFH     5/25/2017
Sanofi (SNY) And Regeneron (REGN) Announce FDA Approval Of A New Once-Monthly Dosing Option For Praluent (Alirocumab) Injection     4/25/2017
Phosphorus Diagnostics Launches Genetic Tests For Inherited Cardiology Diseases Associated With Sudden Death And High Cholesterol     3/17/2017
American Academy of Orthopaedic Surgeons Release: Study Links High Cholesterol Levels With Rotator Cuff Surgery Failure; Statin Use Prior To Surgery Decreases Risk     3/14/2017
Amgen (AMGN) Release: Repatha (Evolocumab) Demonstrates Reduced Need For Apheresis In Patients With High LDL Cholesterol In Phase III Study     3/13/2017
Amgen (AMGN) Wins European Commission (EC) Approval for Repatha Single-Dose Delivery Option     2/23/2017
Madrigal Announces The Initiation Of A Phase II Study Of MGL-3196 In Patients With Heterozygous Familial Hypercholesterolemia (HeFH)     2/23/2017
Esperion (ESPR) Release: Pharma Completes Enrollment Of Pivotal Phase 3 Long-Term Safety And Tolerability Study Of Bempedoic Acid In Patients With Hypercholesterolemia     1/25/2017
Akcea Therapeutics, Ionis Pharma (IONS) Phase 3 COMPASS Met Primary Endpoint     12/19/2016

//-->